Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Research area

Schizophrenia medication trials

You can start by finding out whether a study may be a fit, and CNS Medication Trials can help you with that. Schizophrenia studies look at investigational medications and support programs, some of them aimed at symptoms that current care leaves unaddressed.

Updated

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Schizophrenia medication studies in numbers

schizophrenia medication studies recruiting in the U.S.
61
states with a study site
34
studies that accept healthy volunteers
6

Source: ClinicalTrials.gov. Data processed .

Find schizophrenia medication studies by state

These states have the most studies recruiting right now.

Schizophrenia medication studies recruiting now

As of November 17, 2026, 61 schizophrenia medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.

What they test

  • medications61
  • other approaches4
  • devices2
  • behavioral approaches such as talk therapy or training1

A study can test more than one.

Main purpose

  • treating a condition53
  • basic science4
  • other purposes4

Phase

  • Early Phase 12
  • Phase 17
  • Phase 1/24
  • Phase 29
  • Phase 2/32
  • Phase 322
  • Phase 415

Who runs them

  • industry36
  • university, hospital or other24
  • government1

Who they enroll

  • adults (18 to 64)54
  • older adults (65 and over)31
  • children (under 18)9

6 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 61 studies.

Recently updated schizophrenia medication studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

    • Phase 3
    • Ages 18 to 55
    • All sexes
    Sponsor
    Minerva Neurosciences
    Recruiting in
    Atlanta, GA · Bellflower, CA · Culver City, CA · and 10 more U.S. locations
    Registry record
    NCT07565428 · updated
  2. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Recruiting in
    Alexandria, LA · Anaheim, CA · Augusta, GA · and 31 more U.S. locations
    Registry record
    NCT06887192 · updated
  3. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Anaheim, CA · Atlanta, GA · Boston, MA · and 11 more U.S. locations
    Registry record
    NCT07288567 · updated
  4. A Study to Evaluate the Effect of KarXT on Urological Safety

    • Phase 4
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Bellflower, CA · Boynton Beach, FL · Chicago, IL · and 11 more U.S. locations
    Registry record
    NCT07221877 · updated
  5. A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia

    • Phase 1
    • Ages 18 to 65
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    Bentonville, AR
    Registry record
    NCT07908680 · updated
  6. A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    Anaheim, CA · Atlanta, GA · Boston, MA · and 11 more U.S. locations
    Registry record
    NCT07424404 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in the United States on ClinicalTrials.gov.

What schizophrenia studies look at

What you would be asked to do depends on which study you look at, because each schizophrenia study is built around a single question. Some examine investigational medications. Others examine support programs. Among them are options aimed at symptoms that current care leaves unaddressed.

Keep one word in mind as you read through CNS Medication Trials: investigational. It applies to whatever a study is testing. Its risks, and how well it works, are things researchers have not finished learning about. A study exists to fill in those gaps.

Who may be able to take part

Sorting out whether you are eligible is not your job. A study team does that with you during a screening visit, and our guide explains what eligibility checks and screening involve.

Each schizophrenia study you find through CNS Medication Trials comes with its own list of requirements. Your age can matter. So can your health history, the medications you take now, and how the condition affects you. Some studies also enroll people who do not have the condition.

What taking part usually involves

  1. A first conversation

    First comes a conversation. A coordinator gives you a broad outline of the schizophrenia study, and any questions you raise get answered before a single further thing happens.

  2. Informed consent

    The study team then puts the complete details in writing for you, and the risks known so far are part of that. Agreeing or not is your call.

  3. Screening

    Next, you answer questions about your health and have some tests. The results show whether the trial suits you. Some people who go through screening do not end up taking part.

  4. Study visits

    Joining means visits on a set schedule, which the team uses to keep track of your health. It stays your choice throughout. You can walk away from the study at any point.

Questions about schizophrenia medication studies

Do I need a diagnosis to join a study about schizophrenia?

You will find out from the team running the particular study, because the rule varies. A confirmed diagnosis is required for some schizophrenia studies. In others, the assessment is done as part of screening.

Would I have to change the care I receive now?

The study doctor reviews the care you have now together with you. Before you make a decision, your own doctor can be part of that conversation too. Whether existing care carries on during a study varies: it is allowed in some and not in others. Whatever the study, please make no changes to your care by yourself.

Is there a cost to take part?

As a participant, you will generally find that study visits, study tests, and the study medication come at no cost to you. Read more about costs.

Ask about schizophrenia medication studies

Give CNS Medication Trials a few details about yourself and expect to hear from a coordinator. Asking about schizophrenia studies leaves every decision open. Nothing is committed.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call